R 023 (Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg)
Pill imprint R 023 has been identified as Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg.
Aspirin/butalbital/caffeine is used in the treatment of migraine; pain; headache and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
See also related documents.